Odin Health AI takes interoperability to the next level with a transformative, real-world solution that cuts boosts efficiency, drives innovation and cuts Total Cost of Ownership by up to 80%.
Built on deep healthcare integration expertise, it accelerates workflows through AI-driven automation — reducing learning curves, minimising repetitive tasks, and delivering practical, ready-to-use results for real-world scenarios.
Odin Platform offers both API and MCP interfaces, enabling seamless integration and reuse of functional workflows across API, LLMs and AI Agents.
Cluster Edition
Odin NeXT
Enterprise AO Edition
Standard Edition
Founded in 2014 and headquartered in Auckland, New Zealand, ODIN is a global leader in healthcare interoperability and AI orchestration.
ODIN provides hospitals, healthcare groups, and regional health systems with secure, scalable integration and orchestration capabilities through the ODIN Integration Platform. Through a unified AI Orchestration Layer, ODIN connects EMRs, LIS, RIS, PACS, medical devices and FHIR/API services, enabling AI agents to collaborate safely across systems, organisations and care settings.
ODIN combines healthcare-native interoperability, high availability and cloud-native scalability to deliver:
Today, ODIN supports more than 1,000 hospitals, 1,000 clinics, and 15 cities worldwide, collectively supporting over 500 million outpatient visits every year.
In New Zealand, Odin is backed by strong government support. We’ve been awarded up to NZD 15 million through MBIE’s National Innovation Growth Grant, are part of NZTE Focus 700 program, and proudly carry the FernMark—New Zealand’s global mark of trust.
At ODIN, we believe healthcare AI should be connected, governed and actionable.
This trademark, issued by the New Zealand government, is a global symbol of trust, showing Odin meets the FernMark Licence Programme's eligbility criteria.
Part of NZTE Focus 700 group, working with high-growth, globally competitive companies to deliver maximum international impact.
A multi-year co-funding grant from MBIE Callaghan Innovation, supporting up to NZD 15 million for R&D investment and growth.
The highest EMR Adoption Model rating, recognising advanced EMR technology that improves clinical outcomes, engagement, and operational performance.